1 |
He YY, Jiang LJ: Synthesis and EPR investigations of new aminated hypocrellin derivatives. Free Radic Biol Med 28; 1642-1651, 2000.
DOI
ScienceOn
|
2 |
Wan XY, Chen YT: Hypocrellin A, a new drug for photochemotherapy. Chinese Sci Bull 26;1040-1041, 1981.
|
3 |
Lee YR, Yang IH, Lee YH, Im SA, Song S, Li H, Han K, Kim K, Eo SK, Lee CK: Cyclosporin A and tacrolimus, but not rapamycin, inhibit MHC-restricted antigen presentation pathways in dendritic cells. Blood 105;3951-3955, 2005.
DOI
ScienceOn
|
4 |
Lee YH, Lee YR, Kim KH, Im SA, Song S, Lee MK, Kim Y, Hong JT, Kim K, Lee CK: Baccatin III, a synthetic precursor of taxol, enhances MHC-restricted antigen presentation in dendritic cells. Int Immunopharmacol 11; 985-991, 2011.
DOI
ScienceOn
|
5 |
Ackerman AL, Cresswell P: Cellular mechanisms governing cross-presentation of exogenous antigens. Nat Immunol 5; 678-684, 2004.
|
6 |
Harding CV: Phagocytic processing of antigens for presentation by MHC molecules. Trends Cell Biol 5;105-109, 1995.
DOI
ScienceOn
|
7 |
Heath WR, Carbone FR: Cross-presentation, dendritic cells, tolerance and immunity. Annu Rev Immunol 19;47-64, 2001.
DOI
ScienceOn
|
8 |
Carbone FR, Kurts C, Bennett SR, Miller JF, Heath WR: Cross-presentation: a general mechanism for CTL immunity and tolerance. Immunol Today 19;368-373, 1998.
DOI
ScienceOn
|
9 |
Groothuis TA, Neefjes J: The many roads to crosspresentation. J Exp Med 202;1313-1318, 2005.
DOI
ScienceOn
|
10 |
Kovacsovics-Bankowski M, Rock KL: A phagosome-to- cytosol pathway for exogenous antigens presented on MHC class I molecules. Science 267;243-246, 1995.
DOI
|
11 |
Ojcius DM, Gapin L, Kourilsky P: Dissociation of the peptide/ MHC class I complex: pH dependence and effect of endogenous peptides on the activation energy. Biochem Biophys Res Commun 197;1216-1222, 1993.
DOI
ScienceOn
|
12 |
Diwu Z: Novel therapeutic and diagnostic applications of hypocrellins and hypericins. Photochem Photobiol 61;529- 539, 1995.
DOI
ScienceOn
|
13 |
Ma JS, Yan F, Wang CQ, An JY: Hypocrellin-A sensitized photooxidation of bilirubin. Photochem Photobiol 50;827- 830, 1989.
DOI
ScienceOn
|
14 |
Schinazi RF, Chu CK, Babu JR, Oswald BJ, Saalmann V, Cannon DL, Eriksson BF, Nasr M: Anthraquinones as a new class of antiviral agents against human immunodeficiency virus. Antiviral Res 13;265-272, 1990.
DOI
ScienceOn
|
15 |
Daub ME, Ehrenshaft M: The photoactivated cercospora toxin cercosporin: Contributions to Plant Disease and Fundamental Biology. Annu Rev Phytopathol 38;461-490, 2000.
DOI
ScienceOn
|
16 |
Diwu Z, Zimmermann J, Meyer T, Lown JW: Design, synthesis and investigation of mechanisms of action of novel protein kinase C inhibitors: perylenequinonoid pigments. Biochem Pharmacol 47;373-385, 1994.
DOI
ScienceOn
|
17 |
Ma L, Tai H, Li C, Zhang Y, Wang ZH, Ji WZ: Photodynamic inhibitory effects of three perylenequinones on human colorectal carcinoma cell line and primate embryonic stem cell line. World J Gastroenterol 9;485-490, 2003.
DOI
|
18 |
Liang XH, Cai YJ, Liao XR, Wu K, Wang L, Zhang DB, Meng Q: Isolation and identification of a new hypocrellin A-producing strain Shiraia sp. SUPER-H168. Microbiol Res 164;9-17, 2009.
DOI
ScienceOn
|
19 |
Ali SM, Chee SK, Yuen GY, Olivo M: Hypocrellins and hypericin induced apoptosis in human tumor cells: a possible role of hydrogen peroxide. Int J Mol Med 9;461-472, 2002.
|
20 |
Park J, English DS, Wannemuehler Y, Carpenter S, Petrich JW: The role of oxygen in the antiviral activity of hypericin and hypocrellin. Photochem Photobiol 68;593-597, 1998.
DOI
ScienceOn
|
21 |
Ma G, Khan SI, Jacob MR, Tekwani BL, Li Z, Pasco DS, Walker LA, Khan IA: Antimicrobial and antileishmanial activities of hypocrellins A and B. Antimicrob Agents Chemother 48;4450-4452, 2004
DOI
ScienceOn
|
22 |
Gerelchuluun T, Lee YH, Lee YR, Im SA, Song S, Park JS, Han K, Kim K, Lee CK: Dendritic cells process antigens encapsulated in a biodegradable polymer, poly(D,L-lactideco- glycolide), via an alternate class I MHC processing pathway. Arch Pharm Res 30;1440-1446, 2007.
DOI
|